Warning against using erythromycin (even orally) while using protease inhibitors or certain other drugs
- PMID: 15595151
Item in Clipboard
Warning against using erythromycin (even orally) while using protease inhibitors or certain other drugs
AIDS Treat News.
.
Abstract
A study of medical records found that combining the antibiotic erythromycin with strong inhibitors of the liver enzyme CYP3A increased the risk of sudden death from cardiac causes--probably by abnormally raising the blood levels of erythromycin.
Similar articles
-
Combining erythromycin with other drugs may lead to sudden death.Mayo Clin Womens Healthsource. 2005 Mar;9(3):3. Mayo Clin Womens Healthsource. 2005. PMID: 15689849 No abstract available.
-
Oral erythromycin and the risk of sudden death.N Engl J Med. 2005 Jan 20;352(3):301-4; author reply 301-4. doi: 10.1056/NEJM200501203520317. N Engl J Med. 2005. PMID: 15659735 No abstract available.
-
Oral erythromycin and the risk of sudden death.N Engl J Med. 2005 Jan 20;352(3):301-4; author reply 301-4. N Engl J Med. 2005. PMID: 15669119 No abstract available.
-
Inhibition of cytochrome P450 3A: relevant drug interactions in gastroenterology.Digestion. 2003;68(1):41-8. doi: 10.1159/000073224. Epub 2003 Aug 29. Digestion. 2003. PMID: 12949438 Review.
-
Clinically relevant drug interactions with antiretroviral agents.Antivir Ther. 1997 Jul;2(3):149-65. Antivir Ther. 1997. PMID: 11322270 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical